Evidence map›Paper›PMID 28874526›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Identification of individuals by trait prediction using whole-genome sequencing data.

Christoph Lippert, Riccardo Sabatini, M Cyrus Maher, Eun Yong Kang, Seunghak Lee, Okan Arikan, Alena Harley, Axel Bernal, Peter Garst, Victor Lavrenko and 18 more

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. [Application of HIrisPlex-S System in Forensic DNA Phenotyping].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Christoph LippertHuman Longevity, Inc., Mountain View, CA 94303; jcventer@jcvi.org clippert@humanlongevity.com.
Riccardo SabatiniHuman Longevity, Inc., Mountain View, CA 94303.
M Cyrus MaherHuman Longevity, Inc., Mountain View, CA 94303.
Eun Yong KangHuman Longevity, Inc., Mountain View, CA 94303.
Seunghak LeeHuman Longevity, Inc., Mountain View, CA 94303.
Okan ArikanHuman Longevity, Inc., Mountain View, CA 94303.
Alena HarleyHuman Longevity, Inc., Mountain View, CA 94303.
Axel BernalHuman Longevity, Inc., Mountain View, CA 94303.
Peter GarstHuman Longevity, Inc., Mountain View, CA 94303.
Victor LavrenkoHuman Longevity, Inc., Mountain View, CA 94303.
Ken YocumHuman Longevity, Inc., Mountain View, CA 94303.
Theodore WongHuman Longevity, Inc., Mountain View, CA 94303.
Mingfu ZhuHuman Longevity, Inc., Mountain View, CA 94303.
Wen-Yun YangHuman Longevity, Inc., Mountain View, CA 94303.
Chris ChangHuman Longevity, Inc., Mountain View, CA 94303.
Tim LuHuman Longevity, Inc., San Diego, CA 92121.
Charlie W H LeeHuman Longevity, Inc., San Diego, CA 92121.
Barry HicksHuman Longevity, Inc., Mountain View, CA 94303.
Smriti RamakrishnanHuman Longevity, Inc., Mountain View, CA 94303.
Haibao TangHuman Longevity, Inc., Mountain View, CA 94303.
Chao XieHuman Longevity Singapore, Pte. Ltd., Singapore 138542.
Jason PiperHuman Longevity Singapore, Pte. Ltd., Singapore 138542.
Suzanne BrewertonHuman Longevity Singapore, Pte. Ltd., Singapore 138542.
Yaron TurpazHuman Longevity, Inc., San Diego, CA 92121.
Amalio TelentiHuman Longevity, Inc., San Diego, CA 92121.ORCID 0000-0001-6290-7677
Rhonda K RobyHuman Longevity, Inc., San Diego, CA 92121.
Franz J OchHuman Longevity, Inc., Mountain View, CA 94303.
J Craig VenterHuman Longevity, Inc., San Diego, CA 92121; jcventer@jcvi.org clippert@humanlongevity.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prediction of human physical traits and demographic information from genomic data challenges privacy and data deidentification in personalized medicine. To explore the current capabilities of phenotype-based genomic identification, we applied whole-genome sequencing, detailed phenotyping, and statistical modeling to predict biometric traits in a cohort of 1,061 participants of diverse ancestry. Individually, for a large fraction of the traits, their predictive accuracy beyond ancestry and demographic information is limited. However, we have developed a maximum entropy algorithm that integrates multiple predictions to determine which genomic samples and phenotype measurements originate from the same person. Using this algorithm, we have reidentified an average of >8 of 10 held-out individuals in an ethnically mixed cohort and an average of 5 of either 10 African Americans or 10 Europeans. This work challenges current conceptions of personal privacy and may have far-reaching ethical and legal implications.

Indexed as

ConfidentialityDNA FingerprintingModels, GeneticPhenotypeWhole Genome SequencingAdultAge FactorsAlgorithmsBody SizeCohort StudiesData AnonymizationFemaleHumansMaleMiddle AgedPigmentationDNA phenotypinggenome sequencinggenomic privacyphenotype predictionreidentification

Identifiers

PMID28874526
PMCPMC5617305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.